772 related articles for article (PubMed ID: 20464711)
1. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
3. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
Gopinath B; Wescombe L; Nguyen B; Wall JR
Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
[TBL] [Abstract][Full Text] [Related]
4. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?
Lahooti H; Parmar KR; Wall JR
Clin Ophthalmol; 2010 May; 4():417-25. PubMed ID: 20505833
[TBL] [Abstract][Full Text] [Related]
6. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
7. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
8. The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.
Wescombe L; Lahooti H; Gopinath B; Wall JR
Clin Endocrinol (Oxf); 2010 Oct; 73(4):522-8. PubMed ID: 20039900
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto's thyroiditis and ophthalmopathy or isolated upper eyelid retraction.
Wall JR; Lahooti H; El Kochairi I; Lytton SD; Champion B
Clin Ophthalmol; 2014; 8():2071-6. PubMed ID: 25336908
[TBL] [Abstract][Full Text] [Related]
10. Epitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye disease.
de Haan S; Lahooti H; Morris O; Wall JR
Autoimmunity; 2010 Dec; 43(8):698-703. PubMed ID: 20670117
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy.
McCorquodale T; Lahooti H; Gopinath B; Wall JR
Clin Ophthalmol; 2012; 6():1063-71. PubMed ID: 22888204
[TBL] [Abstract][Full Text] [Related]
13. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Mizokami T; Salvi M; Wall JR
J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
15. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocyte transformation to G2s in patients with autoimmune thyroid disease with and without ophthalmopathy.
Chang CH; Yamada M; Blanchard ME; Li AW; Wall JR
Autoimmunity; 2002 Aug; 35(5):313-7. PubMed ID: 12515285
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
Wiersinga WM
J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
[TBL] [Abstract][Full Text] [Related]
18. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
19. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications.
Diana T; Kahaly GJ
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S13-S19. PubMed ID: 29771755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
